BMPR2 and pulmonary hypertension: This resulted to 72% of PAH patients carrying a BMPR2 mutation in the cohort reported by Austin and colleagues, as compared to 17% in the cohort from the New York Presbyterian Pulmonary Hypertension Center [5], and 25% in the French PAH network [6].